Skip to Content

Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht

SRT3: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€788.00ZnrCffnwbpsp

Sartorius Increases 2025 Revenue Growth Outlook and Drivers Remain Intact

Business Strategy and Outlook

Sartorius AG is a leading provider of single-use biopharmaceutical fermentation and fluid management solutions. It offers services ranging from early-stage consultancy to commercial-scale equipment. After an initial period of consultation and customer-partnered engineering work, Sartorius performs custom installation of biomanufacturing systems for its customers, consisting of bioreactors, fermenters, and cell analysis systems. This equipment has high disposable consumable requirements because customized filters are often used for disinfection because of the sensitivity of biochemical processes. The company’s proven expertise in single-use technology and the regulation-validated nature of biomanufacturing gives Sartorius an attractive razor/razor blade model and supports its wide economic moat.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of SRT3 so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center